Fact CheckerSign in

NCT07506317Completed

Comparative Effects of Wim Hoff Method and Box Breathing Method in Mild COPD

Comparative Effects of Wim Hoff Method and Box Breathing on Anxiety, Dyspnea and Peak Expiratory Flow Rate in Mild Copd

Source: ClinicalTrials.gov · Last updated 1 Apr 2026

Brief summary (registry, in English)

The goal of this clinical trial is to support the role of effective, non-pharmacological interventions in the management of the symptoms of mild Chronic Obstructive Pulmonary Disease (COPD) or the anxiety, dyspnea, and peak expiratory flow rate decline. The main questions it aims to answer are * There are no significant effects of wim hoff breathing and box breathing technique on dyspnea, anxiety, and PEFR in mild COPD patients. * There are significant effects of wim hoff breathing and box breathing technique on dyspnea, anxiety, and PEFR in mild COPD patients. There 2 study groups, group A received box breathing technique and Group B of mild COPD patients received wim hoff breathing technique.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
16 Mar 2026
Start date
1 Jan 2025
Primary completion date
1 Oct 2025
Lead sponsor
Riphah International University
Diseases
COPD
NCT number
NCT07506317

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Jan 2025 to the primary completion date, 1 Oct 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • History of other respiratory conditions (asthma, interstitial lung disease, cystic fibrosis) excluded.
  • Patients of cardiovascular conditions were not included.
  • Neurological or psychiatric and cognitive disorders excluded.
  • Recent history of COPD hospitalization.

Other

  • Participants formally engage in pulmonary rehabilitation programs in last 6 months.

Who the study is looking for

  • Male and female patients
  • Age 35 and 50 years
  • Patients diagnosed with mild COPD with and FEV1 80%-85% of predicted.
  • Participants should have physical and cognitive ability to perform and understand exercises.
  • Participants who quit smoking over 6 months

Age in the registry: 35 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bahawal Victoria Hospital BVH Bahawalpur
Coordinator of this site? Confirm its status
Chak Eighty-seven -Twelve LeftPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.